Syndromic multiplex?PCR panels allowed laboratories to rapidly provide highly sensitive and specific test results for a broad range of viruses and bacteria causing upper respiratory illness. Table 3 provides a list of FDA-cleared?syndromic?panels for the?diagnosis?of upper respiratory illnesses.
We aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Case numbers are resurging in parts of the world where the COVID-19 pandemic was waning, falling in places that saw huge surges recently, and just beginning to rise in previously little-impacted parts of the globe.
Studying and analyzing the impact of Coronavirus COVID-19 on the Syndromic Multiplex Diagnostic industry, the report provide in-depth analysis and professtional advices on how to face the post COIVD-19 period.
Market Segment by Product Type
Gastrointestinal Syndromic Multiplex Diagnostic
Central Nervous System Syndromic Multiplex Diagnostic
Others
Market Segment by Product Application
Hospitals
Diagnostics Laboratories
Research Institutes
Others
Finally, the report provides detailed profile and data information analysis of leading company.
Abbott
Luminex
Danaher
Hologic
Bio-Rad Laboratories
Bosch
Qiagen
Danaher
Johnson & Johnson
bioM?rieux
Diagenode Diagnostics
Alveo Technologies
Akonni Biosystems
Mesa Biotech
Applied BioCode
Insights and Tools:
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively.
The data sources include but not limited to reports of companys,international organizations and governments, MMI market surveys,and related industry news.
Analyses of global market trends, with historical data, estimates for 2022 and projections of compound annual growth rates (CAGRs) through 2027
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
In addition, the report provides insight into main drivers,challenges,opportunities and risk of the market and strategies of suppliers. Key players are profiled as well with their market shares in the global market discussed.
Research Objectives
1.To study and analyze the global Syndromic Multiplex Diagnostic consumption (value) by key regions/countries, product type and application, history data from 2017 to 2021, and forecast to 2027.
2.To understand the structure of Syndromic Multiplex Diagnostic market by identifying its various subsegments.
3.Focuses on the key global Syndromic Multiplex Diagnostic manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the Syndromic Multiplex Diagnostic with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of Syndromic Multiplex Diagnostic submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
Global Syndromic Multiplex Diagnostic Market Status and Outlook 2022-2027
Market Study Overview
1.1 Study Objectives
1.2 Syndromic Multiplex Diagnostic Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research methods
1.5 Market Breakdown and Data Triangulation
2 Global Trend Summary
2.1 Syndromic Multiplex Diagnostic Segment by Type
2.1.1 Gastrointestinal Syndromic Multiplex Diagnostic
2.1.2 Central Nervous System Syndromic Multiplex Diagnostic
2.1.3 Others
2.2 Market Analysis by Application
2.2.1 Hospitals
2.2.2 Diagnostics Laboratories
2.2.3 Research Institutes
2.2.4 Others
2.3 Global Syndromic Multiplex Diagnostic Market Comparison by Regions (2017-2027)
2.3.1 Global Syndromic Multiplex Diagnostic Market Size (2017-2027)
2.3.2 North America Syndromic Multiplex Diagnostic Status and Prospect (2017-2027)
2.3.3 Europe Syndromic Multiplex Diagnostic Status and Prospect (2017-2027)
2.3.4 Asia-pacific Syndromic Multiplex Diagnostic Status and Prospect (2017-2027)
2.3.5 South America Syndromic Multiplex Diagnostic Status and Prospect (2017-2027)
2.3.6 Middle East & Africa Syndromic Multiplex Diagnostic Status and Prospect (2017-2027)
2.5 Coronavirus Disease 2019 (Covid-19): Syndromic Multiplex Diagnostic Industry Impact
2.5.1 Syndromic Multiplex Diagnostic Business Impact Assessment - Covid-19
2.5.2 Market Trends and Syndromic Multiplex Diagnostic Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19
3 Competition by Vendors
3.1 Global Syndromic Multiplex Diagnostic Revenue and Market Share by Vendors (2017-2022)
3.2 Global Syndromic Multiplex Diagnostic Industry Concentration Ratio (CR5 and HHI)
3.3 Top 5 Syndromic Multiplex Diagnostic Vendors Market Share
3.4 Top 10 Syndromic Multiplex Diagnostic Vendors Market Share
3.5 Date of Key Vendors Enter into Syndromic Multiplex Diagnostic Market
3.6 Key Vendors Syndromic Multiplex Diagnostic Product Offered
3.7 Mergers & Acquisitions Planning
4 Analysis of Syndromic Multiplex Diagnostic Industry Key Vendors
4.1 Abbott
4.1.1 Company Details
4.1.2 Product Introduction, Application and Specification
4.1.3 Abbott Syndromic Multiplex Diagnostic Gross Margin, and Revenue (2017-2022)
4.1.4 Main Business Overview
4.1.5 Abbott News
4.2 Luminex
4.2.1 Company Details
4.2.2 Product Introduction, Application and Specification
4.2.3 Luminex Syndromic Multiplex Diagnostic Gross Margin, and Revenue (2017-2022)
4.2.4 Main Business Overview
4.2.5 Luminex News
4.3 Danaher
4.3.1 Company Details
4.3.2 Product Introduction, Application and Specification
4.3.3 Danaher Syndromic Multiplex Diagnostic Gross Margin, and Revenue (2017-2022)
4.3.4 Main Business Overview
4.3.5 Danaher News
4.4 Hologic
4.4.1 Company Details
4.4.2 Product Introduction, Application and Specification
4.4.3 Hologic Syndromic Multiplex Diagnostic Gross Margin, and Revenue (2017-2022)
4.4.4 Main Business Overview
4.4.5 Hologic News
4.5 Bio-Rad Laboratories
4.5.1 Company Details
4.5.2 Product Introduction, Application and Specification
4.5.3 Bio-Rad Laboratories Syndromic Multiplex Diagnostic Gross Margin, and Revenue (2017-2022)
4.5.4 Main Business Overview
4.5.5 Bio-Rad Laboratories News
4.6 Bosch
4.6.1 Company Details
4.6.2 Product Introduction, Application and Specification
4.6.3 Bosch Syndromic Multiplex Diagnostic Gross Margin, and Revenue (2017-2022)
4.6.4 Main Business Overview
4.6.5 Bosch News
4.7 Qiagen
4.7.1 Company Details
4.7.2 Product Introduction, Application and Specification
4.7.3 Qiagen Syndromic Multiplex Diagnostic Gross Margin, and Revenue (2017-2022)
4.7.4 Main Business Overview
4.7.5 Qiagen News
4.8 Danaher
4.8.1 Company Details
4.8.2 Product Introduction, Application and Specification
4.8.3 Danaher Syndromic Multiplex Diagnostic Gross Margin, and Revenue (2017-2022)
4.8.4 Main Business Overview
4.8.5 Danaher News
4.9 Johnson & Johnson
4.9.1 Company Details
4.9.2 Product Introduction, Application and Specification
4.9.3 Johnson & Johnson Syndromic Multiplex Diagnostic Gross Margin, and Revenue (2017-2022)
4.9.4 Main Business Overview
4.9.5 Johnson & Johnson News
4.10 bioM
Abbott
Luminex
Danaher
Hologic
Bio-Rad Laboratories
Bosch
Qiagen
Danaher
Johnson & Johnson
bioM